Portrait
Mark Conley , Vice President, Corporate Controller and Treasurer

Mark Conley has served as vice president, corporate controller and treasurer since February 2016, prior to which he served as our director of financial planning & analysis since joining Valeritas in August 2012. Prior to joining Valeritas, Mark was global finance director of the radiation instrumentation business at Thermo Fisher Scientific from 2007 to 2012. In addition, he served at Iron Mountain, Inc. as vice president, financial planning & analysis from 2005 to 2007 and division controller from 1998 to 2004; as chief financial officer & controller at HoltraChem Group from 1996 to 1998; and in successive financial leadership roles, including operations controller at Haemonetics Corporation from 1991 to 1996. Mr. Conley earned a Bachelor of Science in accounting from Oklahoma State University and an MBA from Bryant College and is a certified public accountant.

Scott Huie , VP, Corporate Compliance and Information Systems

Scott Huie joined Valeritas in 2002. He has over 30 years’ experience in medical device, pharmaceutical and combination products and has held roles in product/process development, operations, regulatory and quality. Scott was previously vice president, operations at Fusion Medical Technologies, which was acquired by Baxter Healthcare Corporation. He has also worked at Aradigm, Cygnus Therapeutic Systems, Ciba-Geigy and 3M Company. Scott received his Bachelor of Science in chemical engineering from Rensselaer Polytechnic Institute.

Chris Gregory , Ph.D. , Vice President, Research and Development

Chris Gregory joined Valeritas in March 2013 as vice president of research and development. He has been developing disposable and durable medical devices since 1986. Prior to joining Valeritas, Chris was director of U.S. research and development for ConvaTec Inc., a disposable medical device company that was originally a division of Bristol-Myers Squibb. At ConvaTec, he was responsible for R&D and maintenance for product lines worth $700 million in annual revenue. Before ConvaTec, Chris was group head for medical devices at Sarnoff Corporation, formally the R&D center for RCA Corp. He also held engineering positions in medical device development at Galileo Electro-Optics and Heraeus LaserSonics. Chris earned a Bachelor of Science and Master of Science from Brown University and a Ph.D. in engineering from Rutgers University.

Jeffrey Zajac , Vice President, Operations

Mr. Zajac was promoted to Vice President, Operations in January 2018 after serving as Sr. Director - Operations, Sr. Director – Program Management and Director Operations Program Management since joining Valeritas in 2013. Mr. Zajac brings more than 20 years of manufacturing and operations management experience in medical devices and contract manufacturing to Valeritas. Prior to joining Valeritas, Mr. Zajac spent 4 years with Jabil, a leading manufacturing service provider to the healthcare & life science businesses as a Global Technical Director – Healthcare & Life Sciences,; and 6 years as a Technical Director for Accellent, Inc. a contract design and manufacturing organization focused on the medical marketplace. Mr. Zajac earned a Bachelor of Engineering, degree from Stevens Institute of Technology and an MBA from the University of Rhode Island.

Mike Reed , Vice President, Regulatory Affairs/Quality Assurance

Mike Reed joined Valeritas in 2019. Mike has extensive experience in Quality Assurance and Regulatory Affairs within the Medical Device and Bio-Sciences business segments. He has held positions of increasing responsibility including Quality Engineering Manager, Executive Director, Quality and VP Quality and Regulatory Compliance, with companies including Becton Dickinson, Millipore Corporation and Beckman Coulter. Most recently, Mike has worked at MEDIcept, Inc. as a quality consultant to industry, helping companies improve/update their Quality Management Systems to meet FDA QSRs, ISO 13485, MDD and CMDAS requirements. Mike received a B.S. in Mathematics and Statistics from the University of New Hampshire and a Certificate in Process Improvement from Worcester Polytechnic Institute (WPI). He is also a Certified Quality Engineer and ISO Certified Lead Auditor.

Mark Conley , Vice President, Corporate Controller and Treasurer

Mark Conley has served as vice president, corporate controller and treasurer since February 2016, prior to which he served as our director of financial planning & analysis since joining Valeritas in August 2012. Prior to joining Valeritas, Mark was global finance director of the radiation instrumentation business at Thermo Fisher Scientific from 2007 to 2012. In addition, he served at Iron Mountain, Inc. as vice president, financial planning & analysis from 2005 to 2007 and division controller from 1998 to 2004; as chief financial officer & controller at HoltraChem Group from 1996 to 1998; and in successive financial leadership roles, including operations controller at Haemonetics Corporation from 1991 to 1996. Mr. Conley earned a Bachelor of Science in accounting from Oklahoma State University and an MBA from Bryant College and is a certified public accountant.

Hokan Lars Ojert , Vice President, Sales

Hokan Lars Ojert joined Valeritas in January 2007. Hokan has over 18 years of diabetes sales and marketing experience, most recently with Sanofi and its predecessor companies. During his time at Sanofi, Hokan held numerous leadership positions within sales and marketing. His career has afforded him the experience of launching, selling and marketing products such as Amaryl®, Apidra®, Lantus®, and the OptiClik® and SoloSTAR® pen technologies. He was the U.S. marketing lead on the commercialization of the OptiClik® pen and involved with the pre-market development of the SoloSTAR® pen technology. Along with Hokan's vast sales and marketing experience within the diabetes arena, he also brings significant recruiting and hiring capabilities to our organization. Hokan led a sales-force scale-up initiative within the diabetes sales division in the Southeast United States. Hokan is a graduate of the University of Scranton, where he earned a Bachelor of Science degree in management.

Dave Lewis , Vice President, Marketing

David Lewis joined Valeritas in June 2016. Mr. Lewis brings with him more than 20 years of healthcare industry marketing experience having led product launch teams for both Merck and Bristol-Myers Squibb/AstraZeneca. Mr. Lewis has extensive experience in the diabetes market having served as Senior Director and Team Lead for Merck’s launch of Januvia® followed by his leadership over the global launch of Forxiga® during his tenure with AstraZeneca and Bristol-Myers Squibb as Executive Director of Marketing. Mr. Lewis has also led the development and execution of commercial strategies and plans for several smaller startup bio-pharma companies. Mr. Lewis holds a bachelor of science degree in engineering from Michigan State University and earned his MBA from Purdue University’s Krannert School of Management.

Kyle Treude , Vice President Managed Care

Kyle Treude joined Valeritas in July 2017. Mr. Treude is an accomplished Sales and Market Access leader with over 20 years of sales, sales management and reimbursement channel leadership experience in high growth diabetes device organizations. In 2006, Mr. Treude joined Dexcom in a sales leadership capacity to oversee the first commercial launch of Dexcom’s CGM technology in the US market. He was later promoted in 2010 to develop and execute Dexcom’s Market Access strategies nationally to drive payer adoption of CGM, as well as the development of their distribution channel. Prior to his tenure with Dexcom, he spent six years with Medtronic MiniMed developing and growing the insulin pump and CGM markets. Mr. Treude holds a bachelor of science degree in Biological Sciences from the University of California Santa Barbara and earned his MBA from Arizona State University’s W.P. Carey School of Management.

Carla Nikkel, RD, LD, CDE, CDTC , Vice President, Medical Affairs

Carla Nikkel joined Valeritas in January 2013. Carla has over 25 years of experience in the field of diabetes, most recently as part of the Medical Affairs Team for Amylin Pharmaceuticals where she leveraged scientific evidence for the pre-market development and launch of the first weekly diabetes therapeutic, Bydureon® and continued scientific support for Byetta® and Symlin®.  Prior to her tenure at Amylin, she worked for the metabolic division of Sanofi-Aventis in support of Lantus® and Apidra® and spent many years with Mead Johnson Nutritionals a division of Bristol Myers Squibb. In addition to her industry experience, Carla founded the largest comprehensive nutrition center in Oklahoma specializing in diabetes self-management, weight management and cardio-metabolic disease education. Carla has completed Clinical Research Coordinator training at Northwestern University, is certified in adult weight management by the American Dietetic Association and is certified as a diabetes educator and diabetes technology clinician.  Carla has held multiple leadership positions across professional associations, including the past President of the Oklahoma Dietetic Association and a member of the Board of Directors for the Academy of Certified Diabetes Educators. She has been instrumental in the execution of multiple clinical research studies and has presented research findings at national and international scientific meetings as well as co-authored multiple manuscripts which have appeared in peer-reviewed journals such as Endocrine Practice, Diabetes Therapy, Postgraduate Medicine, and Advances in Therapy.  Carla earned a Bachelor of Science in Nutrition Sciences at Oklahoma State University and completed her internship at Baylor Medical Center.